Protective effects of a novel trimerized sTNFRII on acute liver injury

International Immunopharmacology

Volumn 13, Issue 1, 2012, Pages 88-92

  Zhang, Lin ^c   Luo, Mansheng ^a,b   Liu, Dan ^c   Zhang, Lingmin ^c   Huang, Shigao ^c   Yang, Wenjuan ^c   Cui, Tong ^c   Ma, Honghui ^c   Wang, Zhen ^c   Sun, Qian ^c   Xiong, Chunhui ^c   Zhu, Jianhong ^c   Li, Jinlong ^a   Wu, Xiaobing ^c   Jin, Liqin ^c   Hu, Zhiming ^a   Gao, Jimin ^c  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b JINGGANGSHAN UNIVERSITY   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Acute liver injury; Adiponectin; LPS; sTNFR; TNF antagonist

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; FC RECEPTOR; GALACTOSAMINE; GLOBULAR PROTEIN; HYBRID PROTEIN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR 2;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE ASSOCIATION; DRUG ACTIVITY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LIVER HISTOLOGY; LIVER INJURY; LIVER PROTECTION; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACUTE LUNG INJURY; ADIPONECTIN; ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; CHO CELLS; CRICETINAE; CRICETULUS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RECOMBINANT FUSION PROTEINS; SOLUBILITY; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84859393142     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2012.03.013     Document Type: Article

References (31)

1. M. Grell Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF J Inflamm 47 1995 8 17
2. H. Wajant, K. Pfizenmaier, and P. Scheurich Tumor necrosis factor signaling Cell Death Differ 10 2003 45 65
3. B.B. Aggarwal, S. Shishodia, Y. Takada, D. Jackson-Bernitsas, K.S. Ahn, and G. Sethi TNF blockade: an inflammatory issue Ernst Schering Research Found Workshop 2006 161 186
4. M.B. Arvelo, J.T. Cooper, C. Longo, S. Daniel, S.T. Grey, and J. Mahiou A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis Hepatology 35 2002 535 543
5. R.A. Smith, and C. Baglioni The active form of tumor necrosis factor is a trimer J Biol Chem 562 15 1987 6951 6954
6. E.Y. Jones, D.I. Stuart, and N.P. Walker Structure of tumour necrosis factor Nature 338 6212 1989 225 228
7. B.B. Aggarwal Signalling pathways of the TNF superfamily: a double-edged sword Nat Rev Immunol 3 2003 745 756
8. M.G. Tansey, and D.E. Szymkowski The TNF superfamily in 2009: new pathways, new indications, and new drugs Drug Discov 14 2009 1082 1088
9. J.M. Bathon, R.W. Martin, R.M. Fleischmann, J.R. Tesser, M.H. Schiff, and E.C. Keystone A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis N Engl J Med 343 2000 1586 1593
10. P.E. Lipsky, D.M. van der Heijde, E.W. St Clair, D.E. Furst, F.C. Breedveld, and J.R. Kalden Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group N Engl J Med 343 2000 1594 1602
11. P.E. Scherer, S. Williams, M. Fogliano, G. Baldini, and H.F. Lodish A novel serum protein similar to C1q, produced exclusively in adipocytes J Biol Chem 270 1995 26746 26749
12. W.B. Lau, L. Tao, Y. Wang, R. Li, and X.L. Ma Systemic adiponectin malfunction as a risk factor for cardiovascular disease Antioxid Redox Signal 15 2011 1863 1873
13. S. Hansen, and U. Holmskov Structural aspects of collectins and receptors for collectins Immunobiology 199 1998 165 189
14. S. Chen, Q. He, X. Dong, X. Wu, and J. Gao Eukaryotic expression and bioactivity determination of the fusion protein sTNFRII-gAD consisting of soluble tumor necrosis factor receptor II and globular domain of adiponectin Sheng Wu Gong Cheng Xue Bao 26 2010 207 215
15. A. Kuhla, C. Eipel, N. Siebert, K. Abshagen, M.D. Menger, and B. Vollmar Hepatocellular apoptosis is mediated by TNF alpha-dependent Fas/FasLigand cytotoxicity in a murine model of acute liver failure Apoptosis 13 2008 1427 1438
16. H. Wang, and Y. Li Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice Eur J Pharmacol 534 2006 194 201
17. E.A. Wilhelm, C.R. Jesse, S.S. Roman, C.W. Nogueira, and L. Savegnago Hepatoprotective effect of 3-alkynyl selenophene on acute liver injury induced by D-galactosamine and lipopolysaccharide Exp Mol Pathol 87 2009 20 26
18. J. Dong, Y. Gao, Y. Liu, J. Shi, J. Feng, and Z. Li The protective antibodies induced by a novel epitope of human TNF-alpha could suppress the development of collagen-induced arthritis PLoS One 5 1 2010 e8920
19. C. Galanos, M.A. Freudenberg, and W. Reutter Galactosamineinduced sensitization to the lethal effects of endotoxin Proc Natl Acad Sci U S A 76 1979 5939 5943
20. J.X. Nan, E.J. Park, J.B. Nam, Y.Z. Zhao, X.F. Cai, and Y.H. Kim Effect of Acanthopanax koreanum Nakai (Ar ALIaceae) on D-galactosamine and lipopolysaccharide-induced fulminant hepatitis J Ethnopharmacol 92 2004 71 77
21. H.R. Alexander, B.C. Sheppard, J.C. Jensen, H.N. Langstein, C.M. Buresh, and D. Venzon Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis J Clin Invest 88 1991 34 39
22. Z. Guo, S. Wang, Q. Jiao, M. Xu, and Z. Xu Soluble TNFR II/IgG1 Fc fusion protein treatment in the LPS-mediated septic shock of rats Biomed Pharmacother 63 2009 537 542
23. K.M. Mohler, D.S. Torrance, C.A. Smith, R.G. Goodwin, K.E. Stremler, and V.P. Fung Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists J Immunol 151 1993 1548 1561
24. L. Romics Jr., A. Dolganiuc, K. Kodys, Y. Drechsler, S. Oak, and A. Velayudham Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice Hepatology 40 3 2004 Sep 555 564
25. W. Lesslauer, H. Tabuchi, R. Gentz, M. Brockhaus, E.J. Schlaeger, and G. Grau Recombinant soluble tumor necrosis factor receptor proteins protect mice from lipopolysaccharide-induced lethality Eur J Immunol 21 11 1991 2883 2886
26. M. Nowak, G.C. Gaines, J. Rosenberg, R. Minter, F.R. Bahjat, and J. Rectenwald LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-alpha and the TNF-p55 receptor Am J Physiol Regul Integr Comp Physiol 278 5 2000 R1202 R1209
27. N. Corazza, A. Badmann, and C. Lauer Immune cell-mediated liver injury Semin Immunopathol 31 2 2009 267 277
28. A. Kuhla, C. Eipel, N. Siebert, K. Abshagen, M.D. Menger, and B. Vollmar Hepatocellular apoptosis is mediated by TNF alpha-dependent Fas/Fas Ligand cytotoxicity in a murine model of acute liver failure Apoptosis 13 2008 1427 1438
29. T. Yang, Z. Wang, F. Wu, J. Tan, Y. Shen, and E. Li A variant of TNFR2-Fc fusion protein exhibits improved efficacy in treating experimental rheumatoid arthritis PLoS Comput Biol 6 2010 e1000669
30. P. Charles, M.J. Elliott, D. Davis, A. Potter, J.R. Kalden, and C. Antoni Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis J Immunol 163 3 1999 1521 1528
31. Y. Shi Mechanisms of caspase activation and inhibition during apoptosis Mol Cell 9 2002 459 470